
Opinion|Videos|November 4, 2024
Outcome Measures in Generalized Myasthenia Gravis
Panelists discuss how various outcome measures are utilized in clinical practice to assess and monitor patients with generalized myasthenia gravis.
Advertisement
Video content above is prompted by the following:
- Can you talk about outcome measures in generalized myasthenia gravis and what you use in your practice?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission
2
Understanding the Barriers of Health Insurance in Stroke Rehabilitation Care
3
GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease
4
Evaluating GLP-1 Receptor Agonist Semaglutide in Phase 3 Settings for Alzheimer Disease: The EVOKE Trials
5

































